Results
962
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
962 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EQT | US$32.66 | 0.2% | -22.8% | US$19.6b | US$42.14 | PE27.9x | E40.7% | 1.9% | Energy | ||
SQM | US$36.45 | -2.0% | -41.4% | US$10.4b | US$57.21 | PE391x | E46.7% | 5.8% | Materials | ||
A042510 | ₩2,200.00 | 5.3% | -17.1% | ₩118.9b | n/a | PS2.2x | E66.4% | n/a | Software | ||
DOX | US$87.01 | 2.1% | -2.1% | US$9.9b | US$99.25 | PE19.5x | E24.1% | 2.2% | Software | ||
VENUSPIPES | ₹2,219.20 | -7.0% | 42.0% | ₹47.0b | ₹2,529.60 | PE47x | E29.3% | 0.05% | Materials | ||
2013 | HK$1.28 | 4.9% | -67.0% | HK$3.9b | HK$1.99 | PS1.9x | E113.5% | n/a | Software | ||
ENPH | US$112.91 | -7.9% | -11.6% | US$16.4b | US$128.25 | PE118x | E38.9% | n/a | Semiconductors | ||
ELC | €1.78 | 0.8% | -27.9% | €109.9m | €2.12 | PE44.3x | E73.2% | 2.8% | Consumer Durables | ||
2755 | CN¥10.92 | -2.8% | 44.8% | CN¥10.1b | CN¥13.00 | PE118.5x | E49.8% | 0% | Pharmaceuticals & Biotech | ||
SQN | CHF 288.00 | -4.8% | 68.1% | CHF 4.3b | CHF 308.60 | PE16.7x | E13.1% | 1.5% | Diversified Financials | ||
4072 | JP¥2,691.00 | -3.4% | -14.3% | JP¥28.6b | JP¥3,600.00 | PE16.9x | E21.0% | 3.0% | Software | ||
541974 | ₹835.90 | 1.5% | 124.8% | ₹49.8b | n/a | PE118.3x | E39.0% | 0.05% | Food, Beverage & Tobacco | ||
AFYA | US$16.80 | -2.8% | 7.1% | US$1.5b | US$20.94 | PE15.5x | E20.7% | n/a | Consumer Services | ||
1501 | HK$28.25 | 1.4% | 1.4% | HK$4.9b | HK$35.04 | PE26.9x | E27.2% | 1.0% | Healthcare | ||
DOM | SEK 65.65 | -5.2% | -3.3% | SEK 21.0b | SEK 89.29 | PE17.8x | E26.8% | 2.9% | Automobiles | ||
2268 | HK$19.74 | -4.4% | n/a | HK$23.7b | HK$30.15 | PE36.2x | E27.5% | n/a | Pharmaceuticals & Biotech | ||
MILDEF | SEK 81.60 | 3.6% | 4.2% | SEK 3.3b | SEK 90.50 | PE75.1x | E47.0% | 0.6% | Capital Goods | ||
RCDO | UK£5.10 | 4.1% | -2.7% | UK£317.3m | UK£6.54 | PB1.9x | E57.8% | 2.4% | Commercial Services | ||
IDHC | US$0.37 | -4.0% | -10.4% | US$213.6m | n/a | PE12.7x | E23.7% | n/a | Healthcare | ||
SLEEP | SEK 40.40 | -2.7% | 64.9% | SEK 819.2m | SEK 55.00 | PE14.8x | E20.9% | 5.7% | Software | ||
300049 | CN¥40.11 | -8.0% | 45.3% | CN¥10.7b | n/a | PE80.2x | E43.5% | 0% | Pharmaceuticals & Biotech | ||
ZS | US$157.13 | -19.0% | -0.8% | US$29.2b | US$215.74 | PS11x | E41.5% | n/a | Software | ||
RAJESHEXPO | ₹296.65 | 0.5% | -42.5% | ₹87.6b | ₹600.00 | PE230.3x | E40.1% | 0% | Consumer Durables | ||
PRGS | US$58.18 | 0.6% | -2.0% | US$2.5b | US$63.00 | PE34x | E21.2% | 1.2% | Software |